Journal
ANDROLOGY
Volume 4, Issue 3, Pages 366-381Publisher
WILEY
DOI: 10.1111/andr.12167
Keywords
androgen insensitivity syndrome; androgens; benign prostatic hyperplasia; prostate cancer; spinal and bulbar muscular atrophy
Categories
Funding
- United States Public Health Service Grant [R01CA108512, R21CA193080, R03CA186179]
- VA Merit Award [1I01BX002494]
- Department of Defense [W81XWH-15-1-0558, W81XWH-14-1-0508, W81XWH-14-1-0509]
- Faculty Research Development Grant of Cleveland State University
- Center for Gene Regulation in Health and Disease grant
Ask authors/readers for more resources
The androgen receptor (AR) and the androgen-AR signaling pathway play a significant role in male sexual differentiation and the development and function of male reproductive and non-reproductive organs. Because of AR's widely varied and important roles, its abnormalities have been identified in various diseases such as androgen insensitivity syndrome, spinal bulbar muscular atrophy, benign prostatic hyperplasia, and prostate cancer. This review provides an overview of the function of androgens and androgen-AR mediated diseases. In addition, the diseases delineated above are discussed with respect to their association with mutations and other post-transcriptional modifications in the AR. Finally, we present an introduction to the potential therapeutic application of most recent pharmaceuticals including miRNAs in prostate cancer that specifically target the transactivation function of the AR at post-transcriptional stages.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available